Wells Fargo & Company Denali Therapeutics Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 93,697 shares of DNLI stock, worth $2.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

93,697

Previous 74,321 26.07%

Holding current value

$2.31 Million

Previous $1.73 Million 58.2%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$20.96 - $31.05 $406,120 - $601,624	19,376 Added 26.07%	93,697 $2.73 Million
Q2 2024 Aug 13, 2024	BUY	$14.96 - $23.22 $142,688 - $221,472	9,538 Added 14.72%	74,321 $1.73 Million
Q1 2024 May 10, 2024	SELL	$15.83 - $23.35 $25,043 - $36,939	-1,582 Reduced 2.38%	64,783 $1.33 Million
Q4 2023 Feb 09, 2024	SELL	$16.2 - $23.18 $1.13 Million - $1.61 Million	-69,561 Reduced 51.18%	66,365 $1.42 Million
Q3 2023 Nov 13, 2023	SELL	$20.63 - $30.17 $549,335 - $803,366	-26,628 Reduced 16.38%	135,926 $2.8 Million
Q2 2023 Aug 15, 2023	BUY	$23.37 - $32.96 $876,001 - $1.24 Million	37,484 Added 29.97%	162,554 $4.8 Million
Q1 2023 May 12, 2023	BUY	$21.91 - $32.67 $1.32 Million - $1.97 Million	60,381 Added 93.34%	125,070 $2.88 Million
Q4 2022 Feb 13, 2023	SELL	$26.28 - $33.92 $5,203 - $6,716	-198 Reduced 0.31%	64,689 $1.8 Million
Q3 2022 Nov 14, 2022	SELL	$25.97 - $38.53 $112,164 - $166,411	-4,319 Reduced 6.24%	64,887 $1.99 Million
Q2 2022 Aug 12, 2022	SELL	$20.88 - $35.19 $857,374 - $1.44 Million	-41,062 Reduced 37.24%	69,206 $2.04 Million
Q1 2022 May 16, 2022	SELL	$29.0 - $47.27 $964,772 - $1.57 Million	-33,268 Reduced 23.18%	110,268 $3.55 Million
Q4 2021 Feb 14, 2022	SELL	$42.59 - $55.02 $903,291 - $1.17 Million	-21,209 Reduced 12.87%	143,536 $6.4 Million
Q3 2021 Nov 15, 2021	BUY	$48.48 - $78.23 $822,802 - $1.33 Million	16,972 Added 11.49%	164,745 $8.31 Million
Q2 2021 Aug 16, 2021	BUY	$50.3 - $78.44 $1.59 Million - $2.48 Million	31,649 Added 27.25%	147,773 $11.6 Million
Q1 2021 May 13, 2021	SELL	$53.8 - $81.53 $407,266 - $617,182	-7,570 Reduced 6.12%	116,124 $6.63 Million
Q4 2020 Feb 09, 2021	BUY	$36.89 - $93.56 $1.4 Million - $3.55 Million	37,945 Added 44.25%	123,694 $10.4 Million
Q3 2020 Nov 05, 2020	BUY	$23.13 - $38.84 $132,997 - $223,330	5,750 Added 7.19%	85,749 $3.07 Million
Q2 2020 Aug 13, 2020	SELL	$16.01 - $28.82 $1.27 Million - $2.29 Million	-79,340 Reduced 49.79%	79,999 $1.94 Million
Q1 2020 May 14, 2020	BUY	$14.2 - $27.98 $2.26 Million - $4.46 Million	159,339 New	159,339 $2.79 Million

Others Institutions Holding DNLI

# of Institutions

228

Shares Held

120M

Call Options Held

60.6K

Put Options Held

48.4K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.31B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Denali Therapeutics Inc. Transaction History